Showing results (2321-2330 of 3,161) with videos related to
Sort By:
Pageof 317
Neuro-Oncology|April 11, 2025
BCOR loss promotes both retinoblastoma growth and susceptibility to IGF1R inhibitionSu-Chan Lee, Satoshi Nakata, Lujain Alaali, et al.Neuro-Oncology|April 16, 2025
FOXR2 activation is not exclusive of CNS neuroblastomaAlexa N Siskar, Emily Hanzlik, Maria F Cardenas, et al.Neuro-Oncology|March 22, 2025
Ototoxicity and Cognitive Outcomes among Very Young Children Treated for Brain Tumors: Findings from a Multisite, Prospective, Longitudinal TrialHeather M Conklin, Nicole A Salman, Johnnie K Bass, et al.Neuro-Oncology|March 14, 2025
Dual Inhibition of MAPK and TORC1 Signaling Retards Development of Radiation Resistance in Pediatric BRAFV600E Glioma ModelsFuyang Li, Kathryn M Bondra, Hanzhou Wang, et al.Neuro-Oncology|March 26, 2025
Co-occurrence of congenital anomalies and childhood brain tumors in 22 million live birthsThanh T Hoang, Jeremy M Schraw, Charles Shumate, et al.Neuro-Oncology|March 4, 2025
Applications of Artificial Intelligence and Advanced Imaging in Pediatric Diffuse Midline GliomaAtlas Haddadi Avval, Suneel Banerjee, John Zielke, et al.Neuro-Oncology|June 12, 2024
Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferationYanling Chen, Ran Zhuo, Lichao Sun, et al.Neuro-Oncology|June 3, 2024
Raman-based machine-learning platform reveals unique metabolic differences between IDHmut and IDHwt gliomaAdrian Lita, Joel Sjöberg, David Păcioianu, et al.Neuro-Oncology|July 19, 2024
Risk of new tumor, carotid stenosis, and stroke after stereotactic radiosurgery for pituitary tumor: A multicenter study of 2254 patients with imaging follow-upChloe Dumot, Georgios Mantziaris, Sam Dayawansa, et al.Neuro-Oncology|June 24, 2024
No benefit from TMZ treatment in glioblastoma with truly unmethylated MGMT promoter: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly glioblastoma patientsMonika E Hegi, Felix B Oppong, James R Perry, et al.Pageof 317